Misdiagnosis in patients with diclofenac-induced hemolysis: New cases and a concise review

American Journal of Hematology

Volumn 81, Issue 2, 2006, Pages 128-131

  Ahrens, Norbert ^a   Genth, Ramona ^a   Kiesewetter, Holger ^a   Salama, Abdulgabar ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Diclofenac; Drug dependent antibodies; Drug induced acute renal failure; Drug induced hemolysis; Immune hemolytic anemia

Indexed keywords

ANTIBODY; COMPLEMENT COMPONENT C3D; DICLOFENAC; GLUCOCORTICOID; HEMOGLOBIN; IMMUNOGLOBULIN G;

ACUTE KIDNEY FAILURE; ADULT; AGED; AUTOIMMUNE HEMOLYTIC ANEMIA; CLINICAL ARTICLE; COOMBS TEST; DIAGNOSTIC ERROR; DRUG INDUCED DISEASE; FEMALE; HEMOLYSIS; HUMAN; MALE; PRIORITY JOURNAL; SHORT SURVEY;

AGED; AGED, 80 AND OVER; ANEMIA, HEMOLYTIC, AUTOIMMUNE; ANTIBODIES; COOMBS' TEST; DIAGNOSTIC ERRORS; DICLOFENAC; FEMALE; HEMOLYSIS; HUMANS; KIDNEY FAILURE, ACUTE; MALE; MIDDLE AGED;

EID: 32144462653     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.20494     Document Type: Short Survey

References (29)

1. Mukherjee D, Nissen SE, Topol EJ. Risk of cardiovascular events associated with selective COX-2 inhibitors. JAMA 2001;286: 954-959.
2. Heuft HG, Postels H, Hoppe I, et al. Eine tödlich verlaufene immunhämolytische Anämie nach Applikation von Diclofenac. Beitr Infusionsther 1990;26:412-414.
3. Salama A, Götische B, Mueller-Eckhardt C. Autoantibodies and drug- or metabolite-dependent antibodies in patients with diclofenac-induced immune haemolysis. Br J Haematol 1991;77:546-549.
4. Ahrens N, Genth R, Salama A. Belated diagnosis in three patients with rifampicin-induced immune haemolytic anaemia. Br J Haematol 2002;117:441-443.
5. Salama A, Kroll H, Wittmann G, Mueller-Eckhardt C. Diclofenac-induced immune haemolytic anaemia: simultaneous occurrence of red blood cell autoantibodies and drug-dependent antibodies. Br J Haematol 1996;95:640-644.
6. Lapierre Y, Rigal D, Adam J, et al. The gel test: a new way to detect red cell antigen-antibody reactions. Transfusion 1990;30: 109-113.
7. Salama A, Berghöfer H, Mueller-Eckhardt C. Detection of cell-drug (hapten)-antibody complexes by the gel test. Transfusion 1992;32:554-556.
8. van der Molen-Eyengraam M. Hemolytische anemie door diclofenac. Geneesmiddelenbulletin 2001;35:79.
9. Meyer O, Hoffmann T, Asian T, Ahrens N, Kiesewetter H, Salama A. Diclofenac-induced antibodies to red blood cells and platelets: two case reports and a concise review. Transfusion 2003;43:345-349.
10. Salama A, Mueller-Eckhardt C. Immune-mediated blood cell dyscrasias related to drugs. Semin Hematol 1992;29:54-63.
11. De Vriese AS, Robbrecht DL, Vanholder RC, Vogelaers DP, Lameire NH. Rifampicin-associated acute renal failure: pathophysiologic, immunologic, and clinical features. Am J Kidney Dis 1998;31:108-115.
12. Rossert J. Drug-induced acute interstitial nephritis. Kidney Int 2001;60:804-817.
13. Muthukumar T, Jayakumar M, Fernando EM, Muthusethupathi MA. Acute renal failure due to rifampicin: a study of 25 patients. Am J Kidney Dis 2002;40:690-696.
14. Sachs UJ, Santoso S, Röder L, Smart E, Bein G, Kroll H. Diclofenac-induced antibodies against red blood cells are heterogeneous and recognize different epitopes. Transfusion 2004;44:1226-1230.
15. Ciucci AG. A review of spontaneously reported adverse drug reactions with diclofenac sodium (Voltarol). Rheumatol Rehabil 1979;(Suppl 2):116-121.
16. Salvarini C, Iori I, Rossi F, Macchioni P, Filippi G. Hypersensitivity to diclofenac with acute hepatitis, immune-haemolytic anaemia, thrombocytopenia and renal involvement. Ital J Gastroenterol 1984;16:54-58.
17. Kramer MR, Levene C, Hershko C. Severe reversible autoimmune haemolytic anaemia and thrombocytopenia associated with diclofenac therapy. Scand J Haematol 1986;36:118-120.
18. Diggory P, Golding RL, Lancaster R. Renal and hepatic impairment in association with diclofenac administration. Postgrad Med J 1989;65:507-508.
19. Bondeson J, Berglund S. Diclofenac-induced thrombocytopenic purpura with renal and hepatic involvement. J Intern Med 1991; 230:543-547.
20. Jick H, Derby LE, Garcia Rodriguez LA, Jick SS, Dean AD. Nonsteroidal antiinflammatory drugs and certain rare, serious adverse events: a cohort study. Pharmacotherapy 1993;13: 212-217.
21. Okada H, Suzuki H, Awaya N, et al. Serious adverse effects induced by simultaneous administration of two nonsteroidal anti-inflammatory drugs. South Med J 1993;86:1266-1268.
22. Lopez A, Linares M, Sanchez H, Blanquer A. Autoimmune hemolytic anemia induced by diclofenac. Ann Pharmacother 1995;29: 787.
23. Bougie D, Johnson ST, Weitekamp LA, Aster RH. Sensitivity to a metabolite of diclofenac as a cause of acute immune hemolytic anemia. Blood 1997;90:407-413.
24. de Quiros JF, Pinto V, Hevia S, Vigon R. Immune complex-mediated haemolytic anaemia and Evans syndrome induced by diclofenac. Vox Sang 1997;72:121-123.
25. Laidlaw ST, Stamps R, Booker DJ, Brown MJ, Sokol RJ. Immune hemolytic anemia due to diclofenac. Immunohematology 1997;13:9-11.
26. Wittmann G, Hahn U, Poley S, Mempel W. Relative frequency of diclofenac-induced immune hemolytic anemia. Transfusion 1999;39:S177-P (abstract).
27. Mazzone M, Siciliano M, Carella G. Multiple diclofenac-induced adverse effects. Am J Gastroenterol 2000;95:2988-2989.
28. Jürgensen JS, Seltsam A, Jörres A. Fatal acute diclofenac-induced immune hemolytic anemia. Ann Hematol 2001;80:440-442.
29. Ahrens N, Schewior L, Garbe E, Kiesewetter H, Salama A. Massive haemolysis after intramuscular diclofenac in a patient who apparently tolerated oral medication. Vox Sang 2004;86:71-74.